Shkreli, Turing, and PhRMA
There have been a few developments in the Turing Pharmaceuticals affair. Martin Shkreli, after given several fantastically annoying interviews, finally reversed…
Derek Lowe's commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine.
-
-
Martin Shkreli Has One Idea, And It’s a Bad One
Martin Shkreli may finally have overstepped, and it will be a good thing if he has. Let me back up both those statements. Shkreli, you may recall, was the found… -
France Elbows Roche Aside on Avastin
The potential off-label use of Avastin for wet age-related macular degeneration has been a source of many arguments over the last few years. The arguments come… -
Thiola, Retrophin, Martin Shkrell, Reddit, and More
Well, it was not a dull evening around the In the Pipeline headquarters last night. I submitted a link to Reddit for my post yesterday about Retrophin and Thiol… -
The Most Unconscionable Drug Price Hike I Have Yet Seen
There’s a drug called Thiola (tiopronin) that most people have never heard of. It’s on my list of “smaller than aspirin” drugs, and I… -
Incomprehensible Drug Prices? Think Again.
There’s a post by Peter Bach, of the Center for Health Policy and Outcomes, that’s been getting a lot of attention the last few days. It’s cal… -
The Hep C Field Gets Nastier By the Minute
What a mess there is in the hepatitis C world. Gilead is, famously, dominating the market with Sovaldi, whose price has set off all sorts of cost/benefit debate… -
The Real Numbers on Tamiflu
I’ve been meaning to cover this controversy about Tamiflu (oseltamivir). The Cochrane group has reviewed all the clinical data obtainable on the drug̵… -
Pfizer Seeks Respect
Here’s Ian Read of Pfizer, on that company’s reputation (and that of pharma in general): . . .many people — including not only regulators but also… -
Should Drug Industry Research All Get Rejected For Publication?
If you work in the drug industry, and for some reason you feel that your blood pressure isn’t quite high enough today, a look at this debate at the Britis…
